Joanna Horobin, M.B., CH.B.
Dr. Horobin has more than 30 years of successful pharmaceutical development experience. She was most recently Senior Vice President and Chief Medical Officer at Idera Pharmaceuticals, Inc. Prior to that, she held positions as Chief Medical Officer at Verastem, Inc., CEO of Syndax Pharmaceuticals, Inc. and several roles of increasing responsibility at global pharmaceutical corporations such as Rhône-Poulenc Rorer (now Sanofi). Dr. Horobin played significant leadership roles in the approvals of several prominent drugs across a breadth of therapeutic indications including oncology, cardiology, pulmonary, antibacterial and chronic pain. Dr. Horobin received her medical degree from the University of Manchester, England. She currently serves on the boards of Kymera Therapeutics and Nordic Nanovector ASA.